Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 285

Similar articles for PubMed (Select 9856616)

1.
2.
3.

Managed care and the quality of substance abuse treatment.

Shepard DS, Daley M, Ritter GA, Hodgkin D, Beinecke RH.

J Ment Health Policy Econ. 2002 Dec;5(4):163-74.

PMID:
14578550
4.
5.
6.

Managed care, networks and trends in hospital care for mental health and substance abuse treatment in Massachusetts: 1994-1999.

Fleming E, Lien H, Ma CT, McGuire TG.

J Ment Health Policy Econ. 2003 Mar;6(1):3-12.

PMID:
14578543
7.

Substance abuse service utilization under managed care: HMOs versus carve-out plans.

Stein B, Reardon E, Sturm R.

J Behav Health Serv Res. 1999 Nov;26(4):451-6.

PMID:
10565105
8.

Costs and utilization of substance abuse care in a privately insured population under managed care.

Schoenbaum M, Zhang W, Sturm R.

Psychiatr Serv. 1998 Dec;49(12):1573-8.

PMID:
9856619
9.

Effects of a statewide carve out on spending and access to substance abuse treatment in Massachusetts, 1992 to 1996.

Shepard DS, Daley M, Ritter GA, Hodgkin D, Beinecke RH.

Health Serv Res. 2001 Dec;36(6 Pt 2):32-44.

10.

Costs and incentives in a behavioral health carve-out.

Ma CA, McGuire TG.

Health Aff (Millwood). 1998 Mar-Apr;17(2):53-69.

11.

Factors associated with the receipt of treatment following detoxification.

Mark TL, Dilonardo JD, Chalk M, Coffey R.

J Subst Abuse Treat. 2003 Jun;24(4):299-304.

PMID:
12867203
12.

Shifting to outpatient care? Mental health care use and cost under private insurance.

Leslie DL, Rosenheck R.

Am J Psychiatry. 1999 Aug;156(8):1250-7.

PMID:
10450268
13.

Mental health/substance abuse treatment in managed care: the Massachusetts Medicaid experience.

Callahan JJ, Shepard DS, Beinecke RH, Larson MJ, Cavanaugh D.

Health Aff (Millwood). 1995 Fall;14(3):173-84.

14.

Managed care and children's behavioral health services in Massachusetts.

Dickey B, Normand SL, Norton EC, Rupp A, Azeni H.

Psychiatr Serv. 2001 Feb;52(2):183-8.

PMID:
11157116
15.
16.

Estimating Determinants of Multiple Treatment Episodes for Substance Abusers.

Goodman AC, Hankin JR, Kalist DE, Peng Y, Spurr SJ.

J Ment Health Policy Econ. 2001 Jun 1;4(2):65-77.

PMID:
11967467
17.

Benefit limits in managed behavioral health care: do they matter?

Peele PB, Lave JR, Xu Y.

J Behav Health Serv Res. 1999 Nov;26(4):430-41.

PMID:
10565103
18.

The high cost of spending less on care.

Sharfstein SS.

Psychiatr Serv. 1998 Dec;49(12):1523. No abstract available.

PMID:
9856609
19.

Organizational and client determinants of cost in outpatient substance abuse treatment.

Beaston-Blaakman A, Shepard D, Horgan C, Ritter G.

J Ment Health Policy Econ. 2007 Mar;10(1):3-13.

PMID:
17417043
20.

The effects of copayments on substance abuse treatment expenditures and treatment reoccurrence.

Lo Sasso AT, Lyons JS.

Psychiatr Serv. 2002 Dec;53(12):1605-11.

PMID:
12461223
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk